title: Reply to Badri et al. on 'Limited benefit of antiretroviral resistance testing in treatment-experienced patients: a meta-analysis'.
authors.forename: Thomas A
authors.initials: TA
authors.lastname: Trikalinos
authors.forename: Ermioni T
authors.initials: ET
authors.lastname: Panidou
authors.forename: John Pa
authors.initials: JP
authors.lastname: Ioannidis
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D024921:Drug Resistance, Multiple, Viral / Q000235:genetics*; D005838:Genotype; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D015201:Meta-Analysis as Topic
chemical_list: D019380:Anti-HIV Agents; D044966:Anti-Retroviral Agents